14 October 2014

NICE, Level 1, City Tower, Piccadilly Plaza, Manchester

The meeting will start promptly at 10:00 and is expected to finish at approximately 17:00

Please note that this agenda is subject to change prior to the meeting.

Final Agenda

    1. Welcome and introduction to format of meeting
    2. Apologies
    3. Any other business
    4. Minutes from the last Committee meeting held on Wednesday 10 September
    5. Appraisal of collagenase clostridium histolyticum for treating Dupuytren’s contracture
      5.1. Declarations of interest - Part 1 only (open session)
      5.2. Introduction by the Chair, Professor Gary McVeigh - Part 1 only (open session)
      5.3. Presentation by the Chair, Professor Gary McVeigh -Part 1 AND part 2 (open and closed session)
      5.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)
    6. Appraisal of belimumab for the treatment of active autoantibody-positive systemic lupus erythematosus 
      6.1. Declarations of interest - Part 1 only (open session)
      6.2. Introduction by the Chair, Professor Gary McVeigh - Part 1 only (open session)
      6.3. Presentation by the Chair, Professor Gary McVeigh - Part 1 AND part 2 (open and closed session)
      6.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)
    7. Appraisal of paclitaxel as albumin-bound nanoparticles in combination with gemcitabine for previously untreated metastatic pancreatic cancer 
      7.1. Declarations of interest - Part 1 only (open session)
      7.2. Introduction by the Chair, Professor Gary McVeigh - Part 1 only (open session)
      7.3. Presentation by the Chair, Professor Gary McVeigh - Part 1 AND part 2 (open and closed session)
      7.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)
    8. Appraisal of sofosbuvir for treating chronic hepatitis C 
      8.1. Declarations of interest - Part 1 only (open session)
      8.2. Introduction by the Chair, Professor Gary McVeigh - Part 1 only (open session)
      8.3. Presentation by the Chair, Professor Gary McVeigh - Part 1 AND part 2 (open and closed session)
      8.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)


Date, time and venue of next meeting:

Next Technology Appraisal (Committee D) Meeting: Wednesday 12 November 2014, 10:00am, NICE, Level 1, City Tower, Piccadilly Plaza, Manchester, M1 4BT.

 

Please note all timings are approximate.

To print the agenda, please right click and select 'Print' from the menu

To register

You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.

The closing date for registration is Tuesday 30 September 2014 at 5pm. Please note that it may not be possible to accept late registration requests.

 

Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Lee Berry

Please note that registrants wishing to conduct a research study on the committee meeting and/or NICE processes will require prior permission and should contact NICE Enquiry Handling by email nice@nice.org.uk further information about conducting research is also available in our Common Questions and Answers about meetings in public document

 

Registration period: 16 to 30 September 2014
Registration is closed.